Trials
1 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Eligible subjects must be diagnosed with disc herniation and scheduled for discectomy, nucleus pulposus tissue will be collected for cell culture. Cultured cells will be then reintroduced into the degenerated disc via injection. Subjects will undergo multiple follow-up visits after surgery to evaluate safety and efficacy, supplemented with imaging studies to assess disc height, tissue…”In the company’s words, NCT07168603 on ClinicalTrials.gov
- Tested for
- Intervertebral Disc Degeneration
- Main trialPhase 1/2
- “This is an open-label, single-center Phase I/II clinical trial investigating the safety and efficacy of autologous nucleus pulposus cells (aNPC) in patients with disc degeneration. Eligible participants are those assessed by the principal investigator to have disc herniation suitable for discectomy and confirmed disc degeneration. During the treatment period, participants will receive a single injection of autologous nucleus pulposus cells at a concentration of approximately 1×10⁶ viable cells/mL with a total volume not exceeding 3 mL. The injection will be guided by C-arm X-ray to ensure…”In the company’s words, NCT07168603 on ClinicalTrials.gov
- Other names
- Autologous Nucleus Pulposus Cells
Other drugs for Intervertebral Disc Degeneration
- Rexlemestrocel-LMesoblast, Ltd. · Phase 3
- IDCTDiscGenics, Inc. · Phase 3
- MDT-0123Medtronic Spinal and Biologics · Phase 3
- SB-01Spine BioPharma, Inc · Phase 3
- BRTX-100BioRestorative Therapies · Phase 2
- CELZ-201-DDTCreative Medical Technology Holdings Inc · Phase 1/2
Coming up1
- 1 DecPhase 1/2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1/2Recruiting | 1 Dec 2026 | EvaluatIon of Autologous Nucleus Pulposus Cells (aNPC) in Degenerative Disc Disease |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026